Skip to main content
YUNGJIN PHARM. CO., LTD logo

YUNGJIN PHARM. CO., LTD — Investor Relations & Filings

Ticker · 003520 ISIN · KR7003520004 KO Manufacturing
Open in API
Filings indexed 193 across all filing types
Latest filing 2023-08-31 Regulatory Filings
Country KR South Korea
Listing KO 003520

About YUNGJIN PHARM. CO., LTD

https://eng.yungjin.co.kr/

Yungjin Pharm. Co., Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and sale of pharmaceutical products for domestic and international markets. The company's portfolio includes a range of prescription drugs, with a focus on areas such as cephalosporin antibiotics and antipsychotic medications. Yungjin Pharm is actively involved in advancing its R&D pipeline, which includes collaborative research for treatments of rare conditions like mitochondrial diseases. Leveraging extensive drug production expertise and R&D capabilities, the company operates as a key affiliate within the KT&G Group's bio/pharmaceutical business.

Recent filings

Filing Released Lang Actions
대규모기업집단현황공시[분기별공시(개별회사용)]
Regulatory Filings Classification · 100% confidence The document is a 'Corporate Group Status Disclosure' (기업집단현황공시) filed by Youngjin Pharm, a subsidiary of the KT&G corporate group. It provides specific regulatory disclosures regarding group status, circular shareholding, and inter-company transactions as required by Korean fair trade regulations. Since it is a regulatory disclosure of corporate structure and status that does not fit into financial reporting or specific event categories like M&A or dividends, it is classified as a general regulatory filing.
2023-08-31 Korean
지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항
Regulatory Filings Classification · 100% confidence The document provides specific financial data regarding payment methods, payment periods, and dispute resolution mechanisms for Youngjin Pharm. This type of detailed disclosure regarding operational payment practices and internal governance/dispute resolution does not fit into standard financial reporting categories like 10-K or IR, nor is it an announcement of a report. It is a specific regulatory disclosure required by Korean corporate reporting standards, making 'RNS' (Regulatory Filings) the most appropriate fallback category.
2023-08-11 Korean
반기보고서 (2023.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for Yungjin Pharm. Co., Ltd., covering the period from January 1, 2023, to June 30, 2023. It contains detailed financial statements, management discussion and analysis, and operational data, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2023
2023-08-11 Korean
영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Release' (영업(잠정)실적) for Youngjin Pharm, detailing quarterly financial highlights such as revenue, operating profit, and net income for 2023.2Q. It provides key financial metrics in a summary table format, which is characteristic of an initial earnings announcement rather than a full report or a mere announcement of a report's publication. Therefore, it fits the definition of an Earnings Release (ER). Q2 2023
2023-07-28 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결) and its subsequent amendment (정정신고). It details a contract extension for a pharmaceutical supply agreement. Since it is a specific regulatory disclosure regarding a material contract update that does not fit into categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2023-07-26 Korean
대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]
Major Shareholding Notification Classification · 100% confidence The document is a 'Corporate Group Status Disclosure' (기업집단현황공시) filed by Youngjin Pharm Co., Ltd. under the KT&G business group. This is a mandatory regulatory filing in South Korea required by the Fair Trade Commission to disclose corporate structure, financial status, board composition, and internal transactions. It does not fit into financial reports like 10-K or IR, nor is it an announcement of a report (RPA). As it is a specific regulatory disclosure document required by law, it falls under the 'Regulatory Filings' category.
2023-05-30 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.